SCHEMBL17355033

SCHEMBL17355033

CCCC(C)CCCC1CCC(C2CCC(OC)C(F)C2F)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18088049 0.85 — —
SCHEMBL15250406 0.82 MAPT (0.39) —
SCHEMBL16378173 0.82 MAPT (0.39) —
SCHEMBL15250127 0.74 MAPT (0.33) —
SCHEMBL15752236 0.72 MAPT (0.36) —
SCHEMBL18307208 0.72 MAPT (0.36) —
SCHEMBL16378275 0.71 — —
SCHEMBL17951919 0.70 — —
SCHEMBL15451575 0.70 MAPT (0.31) —
SCHEMBL15451514 0.70 MAPT (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2957618-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2015-12-23 — — EP disclosed
Send feedback